Minoryx Therapeutics

Minoryx Therapeutics

Minoryx Therapeutics

Minoryx is a clinical stage biotech company leading the development of new therapies for XALD and other Inborn Errors of Metabolism.
Raised
$24.8M
Follow us
Alexa global traffic share
Latest funding
€21,300,000
Venture capital (Series B) - 2018
Team Size
1–10
Employees
€21,300,000 Venture capital (Series B)
FinSMEs , PE HUB

Minoryx Therapeutics Raises €21.3M in Series B Funding

Funding Health